Navigation Links
Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates
Date:2/25/2008

BALTIMORE, Feb. 25 /PRNewswire/ -- Newly published data by Dr. J. Barthelow Classen shows that vaccines are particularly likely to cause diabetes in children with a strong family history of insulin dependent diabetes. Previous papers provided proof that vaccines cause diabetes in vaccine recipients at a rate which exceeds their benefit in the general population. New data indicates vaccines are particularly toxic to those with a strong family history of diabetes. For example, the hemophilus vaccine which had been proven to cause diabetes in approximately 1 in every 2,000 immunized children in the general public has now been linked to causing diabetes in 1 in every 50 immunized children (2%) who have a sibling with insulin dependent diabetes. The new data is published in the Open Pediatric Medicine Journal. An accompanying article in the same journal links the hepatitis B vaccine to insulin dependent diabetes.

"The recent data shows that common childhood vaccines are especially dangerous to children with a strong family history of diabetes. Parents of a child with a strong family history of insulin dependent diabetes or other should know that the administration of a full series of vaccines may have a greater than 5% chance of causing their child to develop diabetes."

Classen's research has become widely accepted. To view the published papers and to find out the latest information on the effects of vaccines on autoimmune diseases including insulin dependent diabetes visit the Vaccine Safety Web site http://www.vaccines.net/newpage11.htm

Classen Immunotherapies, Inc.

6517 Montrose Avenue Baltimore, MD 21212 U.S.A.

Tel: (410) 377-8526 Classen@vaccines.net

http://vaccines.net


'/>"/>
SOURCE Classen Immunotherapies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Emergence of Cancer Vaccines Will Be the Key Factor Driving the Pancreatic Cancer Drug Market to More Than Double by 2016
2. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
3. Discovery of new cause of mental retardation simplifies search for treatments
4. New Drug to Prevent Bone Loss Caused by Breast Cancer Treatment
5. ORNL super water repellent could cause big wave in market
6. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
7. Individual differences caused by shuffled chunks of DNA in the human genome
8. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
9. 3 strikes, youre out? Refiling of Amendment to Change Constitution to Criminalize Stem Cell Cures Shows Trouble with Anti-Cures Cause
10. Novocell Reports Successful Use of Stem Cells to Generate Insulin in Mice
11. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... 17, 2017 , ... Academy of Model Aeronautics (AMA), the ... of unmanned aircraft systems (UAS), are launching a joint program to promote safe ... support educational outreach efforts. , AMA and DJI will collaborate on other potential ...
(Date:2/16/2017)... MENLO PARK, Calif. and ... -- Longitude Capital, a private investment firm focused on ... today announced the promotion of Josh Richardson ... Richardson focuses on investments in biotechnology companies.  He ... and has played important roles in Longitude,s investments ...
(Date:2/16/2017)... 2017   Biostage, Inc. (Nasdaq: ... developing bioengineered organ implants to treat cancers and other ... today the closing on February 15, 2017 of its ... stock and warrants to purchase 20,000,000 shares of common ... offering was priced at $0.40 per share of common ...
(Date:2/16/2017)... Malden, MA (PRWEB) , ... February 16, 2017 ... ... viscoelastic 4-level cervical case. Dr. Kingsley Chin, professor and Harvard trained surgeon, completed ... The procedure was performed on a 55-year-old practicing female physician suffering from degenerative ...
Breaking Biology Technology:
(Date:2/1/2017)... 2017 IDTechEx Research, a leading provider of ... the availability of a new report, Sensors for Robotics: Technologies, ... Reading ... ... Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: ...
(Date:1/26/2017)... , Jan. 26, 2017  Crossmatch, a leading provider ... new solution aimed at combatting fraud, waste and abuse ... introduced at the Action on Disaster Relief conference in ... point for UN agencies and foreign assistance organizations throughout ... waste and abuse are a largely unacknowledged problem in ...
(Date:1/24/2017)... 2017 Biopharm Reports has carried out ... of nuclear magnetic resonance spectroscopy (NMR). This involved ... current practices, developments, trends and end-user plans over ... and opportunities. These areas include growth in the ... and innovation requirements, hyphenated NMR techniques, main suppliers ...
Breaking Biology News(10 mins):